Intuitive Surgical, Inc. $ISRG Shares Purchased by Foster Victor Wealth Advisors LLC

Foster Victor Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 22,749 shares of the medical equipment provider’s stock after acquiring an additional 2,915 shares during the quarter. Foster Victor Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $9,855,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Bank of New York Mellon Corp purchased a new stake in Intuitive Surgical in the second quarter worth $1,335,753,000. Arrowstreet Capital Limited Partnership lifted its position in shares of Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Intuitive Surgical by 55.8% during the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock worth $633,505,000 after purchasing an additional 558,099 shares during the last quarter. Amundi boosted its stake in shares of Intuitive Surgical by 8.6% during the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the period. Finally, Temasek Holdings Private Ltd boosted its stake in shares of Intuitive Surgical by 416.4% during the first quarter. Temasek Holdings Private Ltd now owns 227,211 shares of the medical equipment provider’s stock valued at $104,742,000 after purchasing an additional 183,211 shares during the period. Institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q3 revenue increased 21.7% year over year to $3.05 billion, surpassing the $2.91 billion consensus estimate, while adjusted earnings of $3.00 per share exceeded expectations of approximately $2.65. Intuitive Surgical Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Underlying demand remained healthy: worldwide procedures grew approximately 15%, including about 14% growth in da Vinci procedures and 31% growth in Ion procedures. System placements also rose to 546 from 427 a year earlier. Intuitive Announces Third Quarter Earnings
• Positive Sentiment: Several analysts maintained bullish views or raised targets following the report, including JPMorgan, which lifted its target to $475 and kept an Overweight rating, while Bank of America reiterated Buy with a $470 target. Intuitive Surgical Buy Rating Reaffirmed

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the transaction, the executive vice president directly owned 881 shares in the company, valued at $330,877.17. This represents a 8.04% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the executive vice president owned 5,320 shares in the company, valued at approximately $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock valued at $4,891,989 over the last three months. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th. HSBC downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research note on Thursday, July 30th. Evercore set a $430.00 price objective on shares of Intuitive Surgical in a report on Monday, July 6th. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Twenty-five equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $500.13.

Intuitive Surgical Stock Down 2.3%

Shares of NASDAQ ISRG opened at $428.12 on Thursday. The business has a fifty day simple moving average of $393.50 and a two-hundred day simple moving average of $408.89. The firm has a market cap of $151.25 billion, a PE ratio of 49.10, a price-to-earnings-growth ratio of 3.30 and a beta of 1.46. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 17.70% and a net margin of 25.54%. The business had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same period in the prior year, the business earned $2.40 EPS. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.